Pulike Biological Engineering, Inc. (603566.SS)

CNY 13.78

(1.32%)

Market Cap (In CNY)

4.73 Billion

Revenue (In CNY)

1.25 Billion

Net Income (In CNY)

174.51 Million

Avg. Volume

2.55 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
10.8-25.0
PE
-
EPS
-
Beta Value
0.342
ISIN
CNE1000025N0
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Wei Hu
Employee Count
-
Website
https://en.pulike.com.cn
Ipo Date
2015-05-18
Details
Pulike Biological Engineering, Inc. engages in the research and development, production, and marketing of veterinary biological products and drugs. It offers vaccines, antibodies, and medicines for swine and poultry, as well as disinfectants. The company is headquartered in Luoyang, China.